552 related articles for article (PubMed ID: 25091427)
21. Efficient scalable production of therapeutic microvesicles derived from human mesenchymal stem cells.
Cha JM; Shin EK; Sung JH; Moon GJ; Kim EH; Cho YH; Park HD; Bae H; Kim J; Bang OY
Sci Rep; 2018 Jan; 8(1):1171. PubMed ID: 29352188
[TBL] [Abstract][Full Text] [Related]
22. Bone marrow-derived mesenchymal stem cells ameliorate hepatic ischemia reperfusion injury in a rat model.
Kanazawa H; Fujimoto Y; Teratani T; Iwasaki J; Kasahara N; Negishi K; Tsuruyama T; Uemoto S; Kobayashi E
PLoS One; 2011 Apr; 6(4):e19195. PubMed ID: 21559442
[TBL] [Abstract][Full Text] [Related]
23. Mesenchymal stem cells, not conditioned medium, contribute to kidney repair after ischemia-reperfusion injury.
Xing L; Cui R; Peng L; Ma J; Chen X; Xie RJ; Li B
Stem Cell Res Ther; 2014 Aug; 5(4):101. PubMed ID: 25145540
[TBL] [Abstract][Full Text] [Related]
24. The effects of glomerular and tubular renal progenitors and derived extracellular vesicles on recovery from acute kidney injury.
Ranghino A; Bruno S; Bussolati B; Moggio A; Dimuccio V; Tapparo M; Biancone L; Gontero P; Frea B; Camussi G
Stem Cell Res Ther; 2017 Feb; 8(1):24. PubMed ID: 28173878
[TBL] [Abstract][Full Text] [Related]
25. Microvesicles from brain-extract-treated mesenchymal stem cells improve neurological functions in a rat model of ischemic stroke.
Lee JY; Kim E; Choi SM; Kim DW; Kim KP; Lee I; Kim HS
Sci Rep; 2016 Sep; 6():33038. PubMed ID: 27609711
[TBL] [Abstract][Full Text] [Related]
26. Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury.
Bruno S; Grange C; Collino F; Deregibus MC; Cantaluppi V; Biancone L; Tetta C; Camussi G
PLoS One; 2012; 7(3):e33115. PubMed ID: 22431999
[TBL] [Abstract][Full Text] [Related]
27. Ex Vivo Administration of Mesenchymal Stromal Cells in Kidney Grafts Against Ischemia-reperfusion Injury-Effective Delivery Without Kidney Function Improvement Posttransplant.
Lohmann S; Eijken M; Møldrup U; Møller BK; Hunter J; Moers C; Leuvenink H; Ploeg RJ; Clahsen-van Groningen MC; Hoogduijn M; Baan CC; Keller AK; Jespersen B
Transplantation; 2021 Mar; 105(3):517-528. PubMed ID: 32956281
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic effects of human mesenchymal stem cell microvesicles in an ex vivo perfused human lung injured with severe
Park J; Kim S; Lim H; Liu A; Hu S; Lee J; Zhuo H; Hao Q; Matthay MA; Lee JW
Thorax; 2019 Jan; 74(1):43-50. PubMed ID: 30076187
[TBL] [Abstract][Full Text] [Related]
29. Oct-4 Enhanced the Therapeutic Effects of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Acute Kidney Injury.
Zhang ZY; Hou YP; Zou XY; Xing XY; Ju GQ; Zhong L; Sun J
Kidney Blood Press Res; 2020; 45(1):95-108. PubMed ID: 31927554
[TBL] [Abstract][Full Text] [Related]
30. Stem Cell-Derived Exosomes as Treatment for Stroke: a Systematic Review.
Dehghani L; Hashemi SM; Saadatnia M; Zali A; Oraee-Yazdani S; Heidari Keshel S; Khojasteh A; Soleimani M
Stem Cell Rev Rep; 2021 Apr; 17(2):428-438. PubMed ID: 32935221
[TBL] [Abstract][Full Text] [Related]
31. Gene-modified Mesenchymal Stem Cell-based Therapy in Renal Ischemia- Reperfusion Injury.
Xu H; Chen C; Hu L; Hou J
Curr Gene Ther; 2017; 17(6):453-460. PubMed ID: 29446737
[TBL] [Abstract][Full Text] [Related]
32. Rationale of mesenchymal stem cell therapy in kidney injury.
Fleig SV; Humphreys BD
Nephron Clin Pract; 2014; 127(1-4):75-80. PubMed ID: 25343826
[TBL] [Abstract][Full Text] [Related]
33. Exosomes from Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells (hiPSC-MSCs) Protect Liver against Hepatic Ischemia/ Reperfusion Injury via Activating Sphingosine Kinase and Sphingosine-1-Phosphate Signaling Pathway.
Du Y; Li D; Han C; Wu H; Xu L; Zhang M; Zhang J; Chen X
Cell Physiol Biochem; 2017; 43(2):611-625. PubMed ID: 28934733
[TBL] [Abstract][Full Text] [Related]
34. A combination of mesenchymal stem cells and scaffolds promotes motor functional recovery in spinal cord injury: a systematic review and meta-analysis.
Yousefifard M; Nasseri Maleki S; Askarian-Amiri S; Vaccaro AR; Chapman JR; Fehlings MG; Hosseini M; Rahimi-Movaghar V
J Neurosurg Spine; 2019 Nov; 32(2):269-284. PubMed ID: 31675724
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic potential of mesenchymal stem cells in acute kidney injury is affected by administration timing.
Liu X; Cai J; Jiao X; Yu X; Ding X
Acta Biochim Biophys Sin (Shanghai); 2017 Apr; 49(4):338-348. PubMed ID: 28338909
[TBL] [Abstract][Full Text] [Related]
36. Hypoxia-pretreated human MSCs attenuate acute kidney injury through enhanced angiogenic and antioxidative capacities.
Zhang W; Liu L; Huo Y; Yang Y; Wang Y
Biomed Res Int; 2014; 2014():462472. PubMed ID: 25133162
[TBL] [Abstract][Full Text] [Related]
37. Mesenchymal stromal cell-derived extracellular vesicles attenuate lung ischemia-reperfusion injury and enhance reconditioning of donor lungs after circulatory death.
Stone ML; Zhao Y; Robert Smith J; Weiss ML; Kron IL; Laubach VE; Sharma AK
Respir Res; 2017 Dec; 18(1):212. PubMed ID: 29268735
[TBL] [Abstract][Full Text] [Related]
38. Microvesicles derived from human Wharton's jelly mesenchymal stem cells enhance autophagy and ameliorate acute lung injury via delivery of miR-100.
Chen WX; Zhou J; Zhou SS; Zhang YD; Ji TY; Zhang XL; Wang SM; Du T; Ding DG
Stem Cell Res Ther; 2020 Mar; 11(1):113. PubMed ID: 32169098
[TBL] [Abstract][Full Text] [Related]
39. Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells.
Cantaluppi V; Gatti S; Medica D; Figliolini F; Bruno S; Deregibus MC; Sordi A; Biancone L; Tetta C; Camussi G
Kidney Int; 2012 Aug; 82(4):412-27. PubMed ID: 22495296
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic potential of mesenchymal stem/stromal cell-derived secretome and vesicles for lung injury and disease.
Liu A; Zhang X; He H; Zhou L; Naito Y; Sugita S; Lee JW
Expert Opin Biol Ther; 2020 Feb; 20(2):125-140. PubMed ID: 31701782
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
